Sheets Smith Wealth Management raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 11.1% during the second quarter, Holdings Channel reports. The institutional investor owned 9,094 shares of the company’s stock after buying an additional 910 shares during the period. Sheets Smith Wealth Management’s holdings in Acadia Healthcare were worth $449,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its position in Acadia Healthcare by 0.8% in the first quarter. JPMorgan Chase & Co. now owns 7,705,975 shares of the company’s stock worth $335,980,000 after buying an additional 59,735 shares in the last quarter. Vanguard Group Inc. increased its position in Acadia Healthcare by 8.1% in the first quarter. Vanguard Group Inc. now owns 5,743,233 shares of the company’s stock worth $250,404,000 after buying an additional 431,550 shares in the last quarter. BlackRock Inc. increased its position in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. Aristotle Capital Management LLC acquired a new position in Acadia Healthcare during the first quarter worth $140,071,000. Finally, FMR LLC increased its position in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares in the last quarter.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded down 0.02% during mid-day trading on Friday, reaching $50.89. 695,527 shares of the company’s stock traded hands. Acadia Healthcare Company, Inc. has a 1-year low of $32.54 and a 1-year high of $57.29. The firm has a 50 day moving average of $47.24 and a 200 day moving average of $43.11. The firm has a market cap of $4.47 billion, a PE ratio of 295.87 and a beta of 1.14.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.46. The company had revenue of $679.20 million for the quarter, compared to analyst estimates of $691.74 million. Acadia Healthcare had a net margin of 0.53% and a return on equity of 8.89%. The company’s revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.55 earnings per share. Analysts forecast that Acadia Healthcare Company, Inc. will post $2.44 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/07/22/sheets-smith-wealth-management-acquires-910-shares-of-acadia-healthcare-company-inc-achc.html.

A number of research firms recently issued reports on ACHC. Jefferies Group LLC reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 15th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, March 24th. William Blair began coverage on shares of Acadia Healthcare in a research note on Tuesday. They issued an “outperform” rating on the stock. Cantor Fitzgerald reiterated a “hold” rating and issued a $45.00 target price on shares of Acadia Healthcare in a research note on Wednesday, April 26th. Finally, Deutsche Bank AG began coverage on shares of Acadia Healthcare in a research note on Wednesday, April 5th. They issued a “buy” rating and a $53.00 target price on the stock. Three analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $57.23.

In related news, Director Reeve B. Waud sold 50,000 shares of the company’s stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $50.04, for a total value of $2,502,000.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Ronald Morgan Fincher sold 86,483 shares of the company’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the completion of the transaction, the chief operating officer now owns 137,204 shares in the company, valued at $6,095,973.72. The disclosure for this sale can be found here. Insiders sold 968,102 shares of company stock worth $44,283,109 over the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.